VIL
Click for more information
0.00% 1.6¢ verus investments limited

re: Ann: Verus secures AUD$10 million equity ... All,I was happy...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. blastoff
    1,683 Posts.
    clock Created with Sketch.
    14/04/10
    16:25
    Post #: 6573360
    re: Ann: Verus secures AUD$10 million equity ... All,

    I was happy to buy today but dont expect 4c this week.

    Mind you i dont expect 3c either.

    Sooner or later the many eyes watching will see 4c passed however as testing day nears and for those hoping for less than 3c.... dream on.

    I'm sure theres a hopefull AZZ shareholder at 1.9 still forlornly waiting for the stock to come back from 2cwhen it took off. Reverse greed can cost you a fortune.... foregone.

    Blastoff
    VIL Price at posting: 3.6¢ Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SBW Shekel Brainweigh reports a 50% revenue increase in its Retail Innovation suite and delivers the first batch of 20 Smart Bays to Hitachi as part of a larger order
right-arrow Created with Sketch.
NEWS Oversubscribed share purchase plan successfully raises $2.3 million, with all applications accepted in full
right-arrow Created with Sketch.
NEWS Trending Thread: $13.0 million Institutional Placement
right-arrow Created with Sketch.
NVU Nanoveu To Acquire Leading SoC Semiconductor Company
right-arrow Created with Sketch.
NEWS Form 20-F filed to explore U.S. market opportunities through proposed Nasdaq ADS listing, aligning with strategic global growth goals
right-arrow Created with Sketch.
NEWS First-ever treatment for Rett syndrome approved in Canada, opening new possibilities for patients and boosting potential royalty payments—discover more about DAYBUE™'s breakthrough
right-arrow Created with Sketch.
watchlist Created with Sketch. Add VIL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.